Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

GP20 | RACGP
#GP20Connect
GP20 | RACGP
Home

Improving influenza vaccine effectiveness - Cell based vaccine (ON-DEMAND: 25mins)

Presentation Description

Influenza remains the most serious vaccine preventable disease we encounter with high morbidity and mortality, especially at the extremes of age. Current unadjuvanted vaccines in use in Australia vary in their effectiveness each year for several reasons. One of these is the changes which can occur when the vaccine strain is inoculated into eggs. This 'egg adaptation' can lead to a mismatch between the vaccine and the circulating virus even when the original vaccine strain was well matched. Formulating influenza vaccine in cell lines instead of eggs removes this risk and improves vaccine effectiveness. A cell-based influenza vaccine is now licensed in Australia.

This educational session is sponsored by Seqirus. The educational content has been determined independently and does not necessarily represent the views of Seqirus.


Proudly brought to you by our Program partner

Other Suggested Presentations

Live presentation
21 November 2020 1:45 pm
Room 3
Welcomeness in general practice for people with substance use disorders
A/Prof Penny Abbott

Live presentation
21 November 2020 2:00 pm
Room 3
Guidance GP - Pilot of an Antimicrobial stewardship quality improvement activity
A/Prof Jo-Anne Manski-Nankervis

Live presentation
28 November 2020 4:55 pm
Room 1
GP20 close
Dr Sean Stevens